Showing results (81-90 of 86) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Haematologica|November 2, 2023
<i>ASXL1</i> mutations are associated with a response to alvocidib and 5-azacytidine combination in myelodysplastic neoplasmsVladimir Riabov, Qingyu Xu, Nanni Schmitt, et al.Elife|August 30, 2022
Activation of targetable inflammatory immune signaling is seen in myelodysplastic syndromes with SF3B1 mutationsGaurav S Choudhary, Andrea Pellagatti, Bogos Agianian, et al.Science Translational Medicine|March 9, 2022
Blocking UBE2N abrogates oncogenic immune signaling in acute myeloid leukemiaLaura Barreyro, Avery M Sampson, Chiharu Ishikawa, et al.Blood Reviews|March 18, 2023
Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1<sup>st</sup> International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)Jan Philipp Bewersdorf, Zhuoer Xie, Rafael Bejar, et al.Blood Reviews|September 13, 2023
Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS)Maximilian Stahl, Jan Philipp Bewersdorf, Zhuoer Xie, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 25, 2024
Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes-Recommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS])Fnu Aakash, Savanah D Gisriel, Amer M Zeidan, et al.Pageof 9